Annovis Bio, Inc.
(NYSE:ANVS)
$8.47
0.16 (1.93%)
At Close: 4:00 PM
ANVS Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
ANVS Stock Price Today
Annovis Bio, Inc. (ANVS) stock rallied over 12.19% intraday to trade at $8.47 a share on NYSE. The stock opened with a gain of 11.13% at $8.39 and touched an intraday high of $9.10, rising 12.19% against the last close of $7.55. The Annovis Bio, Inc. in stock market went to a low of $8.00 during the session.
ANVS Stock Snapshot
$7.55
Prev. Close
85.26 Million
Market Cap
$8.00
Day Low
$8.39
Open
N/A
Number of Shares
$9.10
Day High
N/A
P/E ratio
-4.27
EPS (TTM)
0.62
Cash Flow per Share
N/A
Free Float in %
0.74
Book Value
482810.00
Volume
ANVS Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta1.35
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Peers
Frequently Asked Questions
What is the current Annovis Bio, Inc. (ANVS) stock price?
Annovis Bio, Inc. (NYSE: ANVS) stock price is $8.47 in the last trading session. During the trading session, ANVS stock reached the peak price of $9.10 while $8.00 was the lowest point it dropped to. The percentage change in ANVS stock occurred in the recent session was 12.19% while the dollar amount for the price change in ANVS stock was $0.92.
ANVS's industry and sector of operation?
The NYSE listed ANVS is part of Biotechnology industry that operates in the broader Healthcare sector. Annovis Bio, Inc. , a clinical stage drug platform company, develops drugs to treat neurodegeneration.
Who are the executives of ANVS?
Dr. Maria L. Maccecchini Ph.D.
Founder, Chief Executive Officer, Pres & Executive Director
Dr. Cheng Fang Ph.D.
Senior Vice President of R&D
Dr. Maria L. Maccecchini Ph.D.
Founder, CEO, Pres & Exec. Director
Dr. Cheng Fang Ph.D.
Sr. VP of R&D
How ANVS did perform over past 52-week?
ANVS's closing price is 0.68% higher than its 52-week low of $7.4 where as its distance from 52-week high of $23.89 is -0.41%.
How many employees does ANVS have?
Number of ANVS employees currently stands at N/A. ANVS operates from 1055 Westlakes Drive, Berwyn, PA 19312, US.
Link for ANVS official website?
Official Website of ANVS is: https://www.annovisbio.com
How do I contact ANVS?
ANVS could be contacted at phone #610 727 3913 and can also be accessed through its website. ANVS operates from 1055 Westlakes Drive, Berwyn, PA 19312, US.
How many shares of ANVS are traded daily?
ANVS stock volume for the day was 482810.00 shares. The average number of ANVS shares traded daily for last 3 months was 84.03 Thousands.
What is the market cap of ANVS currently?
The market value of ANVS currently stands at $85.26 Million with its latest stock price at $8.47 and N/A of its shares outstanding.